Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-inflammatory but Not Insulin-Sensitizing: Effects of Docosahexaenoic Acid Abomasal Infusions on Adipose Tissue in Mid-Lactation Dairy Cows.

Journal of dairy science·2026
Same author

Abomasal infusion of docosahexaenoic acid elevates circulating anti-inflammatory, pro-resolving oxylipins in dairy cows.

Journal of dairy science·2025
Same author

Effect of abomasal infusions of docosahexaenoic acid on nutrient digestibility, plasma fatty acids, and production responses of mid-lactation dairy cows.

Journal of dairy science·2025
Same author

Abomasal infusion of docosahexaenoic acid to mid-lactation cows alters circulating leukocyte profiles and affects immune response to ex vivo bacterial stimulation.

Journal of dairy science·2025
Same author

Oleic acid promotes lipid accumulation in bovine adipocytes: the role of peroxisome proliferator-activated receptor alpha (PPARα) signaling.

Animal : an international journal of animal bioscience·2025
Same author

Effect of weaning strategies on biosynthesis of oxylipids in Holstein dairy calves.

JDS communications·2025

Related Experiment Videos

Management of multidrug-resistant enterococcal infections.

C A Arias1, G A Contreras, B E Murray

  • 1Department of Internal Medicine, Division of Infectious Diseases and Center for the Study of Emerging and Reemerging Pathogens, University of Texas Medical School at Houston, Houston, TX, USA.

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|June 24, 2010
PubMed
Summary

Multidrug-resistant Enterococcus faecium infections present significant treatment challenges due to widespread antibiotic resistance. New therapeutic strategies and clinical studies are urgently needed to combat these severe infections.

Related Experiment Videos

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Enterococci exhibit remarkable adaptability and antibiotic resistance.
  • Multidrug-resistant Enterococcus faecium (E. faecium) is prevalent globally, limiting treatment options.
  • Resistance to ampicillin, vancomycin, and aminoglycosides is common in E. faecium.

Purpose of the Study:

  • To review the challenges in treating multidrug-resistant enterococcal infections.
  • To discuss current and emerging therapeutic options for vancomycin-resistant E. faecium.
  • To highlight the need for further clinical research into novel treatment strategies.

Main Methods:

  • Review of current literature on enterococcal antibiotic resistance.
  • Analysis of the efficacy and limitations of existing and novel antibiotics.
  • Evaluation of clinical data and in vitro/animal studies.

Main Results:

  • Most E. faecium isolates are resistant to traditional antibiotics like ampicillin and vancomycin.
  • Newer agents (linezolid, daptomycin, tigecycline) show in vitro activity but have clinical limitations.
  • Emerging resistance and limited clinical data for agents like oritavancin pose challenges.

Conclusions:

  • Optimal therapies for multidrug-resistant enterococcal infections rely on empirical data.
  • Further clinical studies are essential to evaluate new strategies, including combination therapies.
  • Urgent research is needed for effective treatment of severe vancomycin-resistant E. faecium infections.